- Rho-Proteins and Downstream Pathways as Potential Targets in Sepsis and Septic Shock: What Have We Learned from Basic Research
Maria Luísa da Silveira Hahmeyer et al, 2021, Cells CrossRef - microRNAs: Small molecules with a large impact on colorectal cancer
Sahand Moazzendizaji et al, 2022, Biotechnology and Applied Biochemistry CrossRef - miRNome Profiling Analysis Reveals Novel Hepatocellular Carcinoma Diagnostic, Prognostic and Treatment-Related Candidate Biomarkers: Post hoc Analysis of SORAMIC Trial
Egidijus Morkunas et al, 2024, Digestive Diseases CrossRef - Is depression the missing link between inflammatory mediators and cancer?
Barbara Polityńska et al, 2022, Pharmacology & Therapeutics CrossRef - The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers
Farzad Sadri et al, 2022, DNA and Cell Biology CrossRef - The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma
Alina-Veronica Ghionescu et al, 2023, Frontiers in Pharmacology CrossRef - NEU4 inhibits motility of HCC cells by cleaving sialic acids on CD44
Xiaoqing Zhang et al, 2021, Oncogene CrossRef - Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways
Sara Muhammad El-Hanboshy et al, 2021, Molecular Biology Reports CrossRef - Prevention of Reperfusion Injury in Acute Myocardial Infarction: A “flashback” Journey of Novel Strategies Based on the Potential Therapeutic Role of Antioxidants
Francisco Salazar-Cornejo et al, 2023, Blood Oxidant Ties: The Evolving Concepts in Myocardial Injury and Cardiovascular Disease CrossRef - Corilagin enhances the anti-tumor activity of 5-FU by downregulating the expression of GRP 78
Simin Li et al, 2023, Scientific Reports CrossRef - EPN3 plays oncogenic role in non‐small cell lung cancer by activating the JAK1/2‐STAT3 pathway
Jiguang Meng et al, 2023, Environmental Toxicology CrossRef - Catapol attenuates the aseptic inflammatory response to hepatic I/R injury in vivo and in vitro by inhibiting the HMGB1/TLR-4/NF-κB signaling pathway via the microRNA-410–3p
Zan Jie Feng et al, 2023, Molecular Immunology CrossRef